Prix FOB
Obtenir le dernier prix|
- Minimum Order
Pays:
China
N ° de modèle:
99.5%
Prix FOB:
Localité:
-
Prix de commande minimale:
-
Commande minimale:
-
Packaging Detail:
-
Heure de livraison:
-
Capacité de Fournir:
-
Payment Type:
T/T
Groupe de produits :
China
Personne àcontacter John
Huizhan Road, Ningbo, Zhejiang
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It
was discovered in a U.S. National Cancer Institute program at the
Research Triangle Institute in ***7 when Monroe E. Wall and Mansukh
C. Wani isolated it from the bark of the Pacific yew tree, Taxus
brevifolia and named it taxol. When it was developed commercially
by Bristol-Myers Squibb (BMS) the generic name was changed to
paclitaxel and the BMS compound is sold under the trademark TAXOL.
In this formulation, paclitaxel is dissolved in Cremophor EL and
ethanol, as a delivery agent. A newer formulation, in which
paclitaxel is bound to albumin, is sold under the trademark
Abraxane.
Paclitaxel is now used to treat patients with lung, ovarian,
breast cancer, head and neck cancer, and advanced forms of Kaposi's
sarcoma. Paclitaxel is also used for the prevention of
restenosis.
Â
| Pays: | China |
| N ° de modèle: | 99.5% |
| Prix FOB: | Obtenir le dernier prix |
| Localité: | - |
| Prix de commande minimale: | - |
| Commande minimale: | - |
| Packaging Detail: | - |
| Heure de livraison: | - |
| Capacité de Fournir: | - |
| Payment Type: | T/T |
| Groupe de produits : | API |
